Vistance Networks Stock 250% Signals Post-Divestiture Bet
A high-stakes move by a leading investment manager has turned heads in the tech infrastructure space. This article ex...
Articles — Page 1629
This Elite 5.5%-Yielding Dividend Stock Poised to Grow
Investors chasing income with growth potential often look for a reliable pillar. This elite 5.5%-yielding dividend of...
Kirby Posts $6.33 2025: Fund Bets $25M on Marine Operator
A prominent fund has taken a sizable stake in Kirby Corporation, with eyes on a bold earnings target of $6.33 per sha...
Time Palo Alto Networks: Is It Time to Buy the Dip Now?
Palo Alto Networks has seen a meaningful pullback, but a dip can become a doorway for patient investors. This guide b...
This Fund Dumped Million: Graphic Packaging Stock Selloff and Lessons for Investors
When a well-known fund exits a position, it invites scrutiny. This fund dumped million in Graphic Packaging as shares...
Institutional Investors Just Sent a Historic Warning
A historic $8.3 billion signal from institutional investors just sent a warning about market risk. Learn what it sign...
Investment Firm Purchases Sonos Amid New Product Line Prep
A notable investment firm expanded its Sonos position just as the company prepares a fresh product lineup. This move ...
Agent Created OpenAI Accidentally Sends Crypto Holdings
A prototype AI agent reportedly moved an entire Lobstar token stake to a social-media reply target, booked quick prof...
Dean Capital Bets Energy with a Major CPK Investment
A prominent investment firm just showed its hand in energy delivery by buying a large stake in Chesapeake Utilities. ...
Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Biotech Investor Adds Million as Krystal Biotech Revenue Rises
A major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Investor Slashes Million From Zymeworks as Stock Jumps 60%
A large holder trimmed a substantial stake in a biotech name while the stock advanced. This piece explains what inves...